menu
    • menu

    Company profile for Aclaris Therapeutics

    NEW Drugs in Dev: 15
    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Sharp is a leader in commercial packaging, clinical services, and sterile manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    As a CDMO, Mikart offers integrated CDMO services for Solid Dose & Non-sterile Liquid formulations.

    Virtual Booth

    Contact Supplier

    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Since Aclaris was founded in 2012, our focus has been innovation to help people with underserved dermatologic conditions, taking inspiration from some of the patients our founders saw in clinical practice as dermatologists. We're identifying early-stage drug candidates to create novel medicines for skin and hair disorders. We've built a committed, patient-centric organization of nearly 200 employees, guided by leaders with ...
    Since Aclaris was founded in 2012, our focus has been innovation to help people with underserved dermatologic conditions, taking inspiration from some of the patients our founders saw in clinical practice as dermatologists. We're identifying early-stage drug candidates to create novel medicines for skin and hair disorders. We've built a committed, patient-centric organization of nearly 200 employees, guided by leaders with 250+ years of combined experience in developing and commercializing treatments in dermatology and immunology.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Aclaris TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    640 Lee Road Suite 200 Wayne, PA 19087
    Telephone
    Telephone
    (484) 324-7933
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.aclaristx.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Aclaris Therapeutics to Join BofA 2026 Healthcare Conference
    Aclaris Therapeutics to Join BofA 2026 Healthcare Conference

    08 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/08/3291054/37216/en/aclaris-therapeutics-to-participate-in-the-2026-bank-of-america-healthcare-conference.html

    GLOBENEWSWIRE
    08 May 2026
    Share Share
    Aclaris Reports Positive Phase 1a Data for ATI-052 Antibody
    Aclaris Reports Positive Phase 1a Data for ATI-052 Antibody

    28 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/28/3282383/37216/en/aclaris-therapeutics-announces-positive-full-top-line-first-in-human-results-from-phase-1a-healthy-volunteer-clinical-trial-of-ati-052-a-novel-potential-first-in-class-anti-tslp-il.html

    GLOBENEWSWIRE
    28 Apr 2026
    Share Share
    Aclaris Therapeutics To Update Biologic & Oral Inhibitor Programs
    Aclaris Therapeutics To Update Biologic & Oral Inhibitor Programs

    27 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/27/3282070/37216/en/aclaris-therapeutics-to-provide-clinical-update-on-key-biologic-and-oral-inhibitor-programs-on-april-28-2026.html

    GLOBENEWSWIRE
    27 Apr 2026
    Share Share
    Aclaris to Present at H.C. Wainwright Skin Conference
    Aclaris to Present at H.C. Wainwright Skin Conference

    08 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/08/3270097/37216/en/Aclaris-Therapeutics-to-Participate-in-the-H-C-Wainwright-4th-Annual-Inflammatory-Skin-Disease-Virtual-Conference.html

    GLOBENEWSWIRE
    08 Apr 2026
    Share Share
    Provide Additional Support for Therapeutic Potential of ATI-2138
    Provide Additional Support for Therapeutic Potential of ATI-2138

    27 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/27/3263826/37216/en/Results-Presented-at-2026-American-Academy-of-Dermatology-AAD-Annual-Meeting-Provide-Additional-Support-for-the-Therapeutic-Potential-of-ATI-2138.html

    GLOBENEWSWIRE
    27 Mar 2026
    Share Share
    Aclaris Therapeutics Presents ATI-2138 Phase 2A Trial Results
    Aclaris Therapeutics Presents ATI-2138 Phase 2A Trial Results

    20 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/20/3259830/37216/en/Aclaris-Therapeutics-Announces-Poster-on-Results-from-Phase-2a-Trial-of-ATI-2138-at-the-2026-American-Academy-of-Dermatology-AAD-Annual-Meeting.html

    GLOBENEWSWIRE
    20 Mar 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search